The Brown University spinout wants to apply its algorithms to help improve personalized cancer treatments.
A Brown University-led team demonstrated the utility of its "massively parallel splicing assay," or MaPSy, assay by profiling splice effects for thousands of mutations.
A genome-wide association study and meta-analysis uncovered several possible ties to multiple keratinocyte cancer versus single keratinocyte cancer cases.
The researchers used the ligase to detect Ebola transcripts and suggest it could be applied to in vitro diagnostics and sequencing.
Considering the widespread use of the cell line, these findings could have significant implications for the research community.
A genome-wide association and fine-mapping study of Samoans led to a missense mutation in the CREBRF gene that seems to correspond with increased fat storage.
The new center will focus on supporting and mentoring junior faculty researchers as well as on building bioinformatics infrastructure for projects.
The National Institutes of Health grant will allow the university to build a Center of Biomedical Research Excellence to advance computational biology research.
After closing its doors last September, Nabsys has resumed operations, refocusing on its core technology.
The method simplifies previous techniques, and preliminary testing using a microfluidic device indicates it could ultimately be used in low-resource settings.
A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.
Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.
Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.
In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.